This association of P2X7R and of A2AR with inflammation and infection has prompted multiple opinion papers hypothesizing that the antagonism of P2X7R [29,30,31,32] or activation of A2AR [32,33,34] may afford a benefit to manage COVID-19. Here, ADORA2A is linked to infection.